This inventor holds 2 USPTO granted patents. Top assignee: Research Corporation Technologies, Inc.. Active years: 1993-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ann Arbor, MI (US) (1993)
- Tully, NY (US) (1995)
Company Filing History:
Years Active: 1993-1995
Title: Innovations by Gregory W. Canute
Introduction
Gregory W. Canute is a notable inventor based in Ann Arbor, MI, who has made significant contributions to the field of pharmaceuticals. He holds two patents that focus on compounds with anti-tumor activity, showcasing his dedication to advancing medical science.
Latest Patents
His latest patents include "Phosphoramidates useful as antitumor agents," which describes compounds that possess anti-tumor activity. Another significant patent is for "Cyclophosphamide analogs useful as anti-tumor agents," which details cyclophosphamides that exhibit anti-tumor properties and outlines their chemical structure.
Career Highlights
Gregory W. Canute is associated with Research Corporation Technologies, Inc., where he continues to innovate in the field of cancer treatment. His work has the potential to impact the lives of many patients battling cancer.
Collaborations
He has collaborated with notable colleagues such as Richard F. Borch and Ronald R. Valente, contributing to a rich environment of innovation and research.
Conclusion
Gregory W. Canute's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the development of anti-tumor agents. His contributions are vital to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile